Author: Keagan Kurien

7th March, 2024

Digital technologies have brought in a new wave of innovation to healthcare, transforming the way in which patients access medical services, professionals deliver care, and organizations operate.  

As a pioneer in access to healthcare solutions for over 25 years, Axios International has embraced this transformative wave through Axios+, a comprehensive and integrated digital health ecosystem committed to providing digital accessibility while maintaining a human approach.  

Leveraging data to empower decision-making

Axios+ is more than just a technological advancement. Axios+ enables pharmacists, doctors, laboratories, and various other entities to make quality healthcare accessible to patients, regardless of their location or economic status, and supports patients throughout their treatment journey.  

Interconnectivity is key to providing multi-dimensional support to patients and has proven to have multiple operational benefits for patients and all the parties involved. So, from simplifying the support program introduction of patients for physicians to aiding pharmaceutical companies in monitoring, Axios+ positions itself as an integrated patient-centric technology.  

Axios+ already makes it easier for patients to schedule deliveries, contact our program teams, and report adverse events. As an organization, Axios plans to adopt Artificial Intelligence (AI) in the near future, which will improve productivity and efficiency, smoothen operations, and ultimately improve the handling of patient services.  

For example, AI algorithms can analyze large datasets to identify patterns and trends, aiding disease prevention and early diagnosis, allowing us to collect, view, understand, and process data to make better-informed decisions. Additionally, by utilizing AI tools alongside our Patient Management System, we can further improve data accuracy and consistency, eventually leading to enhanced personalization of our digital tools and predictive models.  

Empowering and enabling patients to receive quality care and treatment

One standout area of the Axios + ecosystem is the MyHealth app, which serves to empower patients. Specifically designed for patients, it sends timely medication reminders, assists in obtaining required medications, and streamlines the entire patient support experience through automated processes. This maximizes treatment adherence and contributes to patients’ overall well-being. As a result, Axios+ patients are better equipped to take control of their treatment by ensuring they have easy access to relevant and timely information. 

At the core of the system is MyHealth, which provides a very practical approach that ensures patients stay on treatment. However, there is still space for AI in this instance without losing the human touch. But that’s just one arm of Axios +, so what does the full ecosystem entail?  

Holistic, customized, and sustainable digital access solutions

• MyPatients for Physicians 
  Available on mobile and desktop, the MyPatients application offers a simple process for registering patients to Axios-managed Patient Support Programs (PSPs). It also helps physicians easily refer patients, upload documents or sign them digitally, and track their progress in the program in real-time.  
  
  
• MyHealth for Patients
  Available on mobile, the MyHealth application gives patients a robust platform to track their treatment regimens and adhere to treatment plans easily. Accessing in-app functionalities, such as viewing medical releases and uploading relevant documents for a comprehensive treatment history, becomes available to patients once they are enrolled in the programs managed by Axios International. They can also view upcoming medical releases and easily obtain their medication from a partnered pharmacy.  
  
  
• MyPharmacy for Pharmacists
  Available on mobile and desktop, MyPharmacy is uniquely developed for pharmacists and pharmacies registered in Axios-managed Access programs. The application enables pharmacists to schedule the release of upcoming prescriptions for each patient and validate any documents they receive using an integrated QR code scanner or security code. In addition to addressing the core needs of patients, doctors, and pharmacists, Axios+ has features that contribute to the overall success of treatment programs.  
  
  
• MyPrograms Dashboard
  Available on desktop, The MyPrograms dashboard allows pharmaceutical companies that are part of the PSPs to view live data on their treatment successes and failures. It simplifies and combines data related to the program to provide a comprehensive overview of up-to-date aggregated and anonymized data. They can view the number of patients by status in the program, track the number of physicians or hospitals referring patients to the program, and view product distribution by commercial type or the number of units.   
  
  
• MyCharity feature
  Available on desktop, MyCharity is a simplified platform that allows charities to track and manage patient charity applications associated with Axios-managed PSPs, fostering a collaborative approach to healthcare. The platform’s success lies in its technological prowess and commitment to a patient-centric approach, creating a more informed, accurate, and accessible foundation for developing, improving, and administering treatments.   
  
  

Axios+, empowering the present, enabling the future

The future of the digital landscape is certainly exciting. Axios+ presently offers an innovative collection of user-friendly digital solutions tailored to different stakeholders. It lays the foundation for leveraging both current and emerging technologies to ensure access to the highest level of care and support for all our patients.   

5th February, 2024

Table of Contents

When Axios International started operations 25 years ago, the focus was on addressing financial barriers that stopped patients from obtaining necessary treatment. Over the course of Axios’ journey in the field of healthcare accessibility, gathered insights showed that beyond affordability, various other barriers throughout the patient journey stopped them from achieving optimal medical outcomes.  

As Axios grew and learned from experience, research, and real-world insights, the complexities beyond affordability were explored to enhance the patient’s journey. Questions including: What can we learn from the Patient Access Programs we designed and managed? How can we keep improving them while looking at factors influencing the patient’s journey? were asked. 

The patient journey: Beyond affordability 

While affordability remains a critical barrier, it is just one facet of the intricate patient journey. Over time, a holistic approach has emerged, and we acknowledge the need to sophisticate strategies and interventions to ensure optimal medical outcomes. The patient journey – depicted as a sequence from disease onset to treatment adherence – also encompasses various stages, such as diagnosis, prescription, compliance, and adherence, which we think is a given. Notably, the complexities intensify outside the hospital setting, particularly in chronic and long-term treatment scenarios, necessitating improvements at every step. 

Understanding influencing factors: A case study 

One pivotal realization in understanding access was that addressing affordability alone did not guarantee success. We had extremely generous programs, but even then, we did not have patients because the doctors didn’t refer them, or sometimes the patients refused to take the treatment when they were referred.  

Despite having a prescription and an affordable program for the patient, we noted that it was unsuccessful. So, what other factors blocked or sometimes facilitated the patient’s outcome? Where was the hiccup? 

We conducted a multi-country, in-depth study with patients and physicians to research willingness to pay and willingness to prescribe and assess why the access programs were unsuccessful. We gave physicians different price ranges and found that at a certain price, regardless of whether you have a program or not, regardless of whether the patient is willing to pay or can afford it or not, physicians will not prescribe because they do not see the value for the patient in getting treated. –

Validating our findings, a case study on asthma patients also showed that perceived value played a crucial role in physician prescription decisions beyond affordability. The study identified a price threshold below which physicians were reluctant to prescribe because they did not perceive the value, emphasizing the necessity to address value perception or value pricing before implementing access programs. 

Tailoring solutions to regional dynamics 

Regional disparities in patient mindset further underscored the need for tailored solutions. For example, a comparative analysis between India and Egypt for asthma treatment highlighted the influence of regional economic factors. In India, patients were unwilling to pay at higher price points even if they could afford it, whereas, in Egypt, a higher cost of asthma treatment influenced both physicians and patients positively.  

This was an eye-opener for us.  

Axios access experts learned not to rush into designing access programs without understanding the physicians’ and patients’ mindset for that disease. These Real-World Insights prompted a re-evaluation of the one-size-fits-all approach, emphasizing the importance of understanding regional specificities before implementing access programs. 

Financial assessment tools: Evolving precision 

Financial assessment tools like Axios’ proprietary Patient Financial Assessment Tool (PFET) are crucial to determining patients’ ability to pay so they can complete the full course of treatment and get the best medical outcomes.  

Since 2006, the tool has been continuously refined as well as validated and published in journals such as Population Health Management and the Journal of Comparative Effectiveness Research. However, despite the presence of a validated tool, there was a need to understand the parameters for accurate financial assessment and what factors influence the patients. 

A study titled: Ability to pay for medication: a cluster analysis of 1404 patients with the Patient Financial Eligibility Tool, examining three countries – Thailand, the United Arab Emirates, and Mexico – was carried out to explore parameters influencing accurate financial assessments. By incorporating income, assets, and standard of living, the tool demonstrated flexibility in addressing diverse economic landscapes, especially in informal economies. It also showed that the standard of living and income are the biggest drivers. Following the outcomes of these studies, assessments were done to understand the country-specificities and improve the tool to overcome some of these barriers.  

Real World Insights: Why adherence matters 

Research done to assess the impact of access programs on patient adherence revealed significant improvements in treatment duration, demonstrating an increased patient adherence from 226 to 465 days on average. These findings emphasized the pivotal role of access programs in enhancing medical outcomes.  

Pharmacists’ Role: A critical insight 

In the pursuit of understanding healthcare providers’ roles, another study done by Axios International acknowledged the often-overlooked significance of pharmacists. The research done in Egypt on Chronic Obstructive Pulmonary Disease (COPD) treatment highlighted that contrary to physicians with a high patient load, smaller pharmacies demonstrated superior patient outcomes. The study also found that small pharmacies serving the community and dealing with fewer patients had a statistically significant better outcome in Egypt compared to pharmacies with many patients. This emphasized the importance of pharmacist-patient interaction, suggesting tailored strategies based on the scale of healthcare providers. A similar study in Lebanon on oncology treatment showed the reverse. Bigger pharmacies handling many patients had statistically significant better adherence and fewer dropouts than smaller pharmacies when it came to oncology treatment because specialized treatment required specific knowledge and expertise.  

Impact of economic crisis on medical outcomes 

A key barrier that must be considered while designing an access program is the economic barrier. 

To illustrate this point and as an example, the unforeseen impact of economic crises on patient outcomes was illuminated through an analysis of Lebanon’s economic downturn since 2019. Patients undergoing cancer treatment experienced a significant decline in survival rates post-crisis, indicating the interplay between economic factors and healthcare system support. While beyond direct influence, such findings underscored the importance of considering external economic factors in patient access strategies. Therefore, the impact of the economic crisis on the medical outcome is an important factor to consider because it shows that economic factors cannot be influenced. 

Quest for access: An enduring and dynamic journey 

The journey of providing access to healthcare is evolving, demanding constant improvement and adaptation. The intricate landscape of patient access is changing, emphasizing the need for comprehensive understanding, continuous questioning, and progressive research to overcome barriers. Axios International’s commitment to optimizing patient outcomes remains unwavering as the healthcare landscape develops, making the quest for access an enduring and dynamic journey. 

26th January, 2024

Many patients, even if they can afford to cover the cost of medication, often face difficulty managing cash flows, especially during long-term treatment plans for chronic conditions. A systematic review of studies shows that when it comes to choosing between expenses, many individuals who suffer from chronic diseases prefer to cut down their expenses on treatments and medicines to save costs. A practical viewpoint shows us that this phenomenon, known as Cost-Related Non-adherence (CRN), is directly related to the rising costs of medication in conjunction with the overall increase in costs of living. Studies also show that many patients with chronic illnesses find it difficult to pay for treatment and medicines because they are already experiencing huge medical expenses for hospitalization, regular checkups, and laboratory testing, among other costs, including expenses related to their standards of living.  

Failing to follow through and complete the treatment course because of financial concerns is a common yet high-risk challenge. While patients may not choose to stop taking medication altogether, many may resort to buying only a portion of the essential or more affordable medications. 

When looking at the long-term implications of this situation, non-adherence to treatment leads to complications for stakeholders involved in the process of providing care and treatment. For patients, non-adherence can include the risk of developing larger, more complicated health issues and comorbidities down the road. For example, when a person with untreated diabetes develops chronic kidney disease, they may end up facing an infinitely more complicated condition. For healthcare providers it further complicates the treatment process, limiting the effectiveness of their course of treatment. Payers who bear the cost of treatment, such as insurers or the government, can face catastrophic outcomes when patient health and medical outcomes are not optimal. For the community at large, it can pose a threat to the outcome of treatment, lower the rate of success, and cause a functioning drug to lose its credibility. Also, specialized care and treatment resources, such as physicians, nurses, and hospitals, are already limited. Not adhering to prescribed treatment procedures reduces the effectiveness of medical care and patient well-being, contributing to the strain on physicians and hospitals, which are already overburdened. 

On-Time Access to Treatment Helps Patients Receive Immediate Financial Support 

Alongside the rapid development of technology and science, there has been a corresponding increase in the number of diseases and individuals suffering from chronic illnesses. If we just take cancer into account, according to data provided by the Centers for Disease Control and Prevention (CDC), in 2017, there were an estimated 18.1 million new cancer cases and 9.6 million cancer deaths worldwide. In 2020, there were an estimated 19.3 million new cancer cases and 10 million cancer deaths worldwide. In 2021, there were an estimated 19.9 million new cancer cases and 10.3 million cancer deaths worldwide, depicting a steady increase in the number of cases. This report from the National Cancer Institute shows that in the future, the number of cases alongside the cancer-attributable costs for medical services and oral prescription drugs are likely to steadily increase. While both these studies confirm that access to newer treatments and medicines and prevention made possible by pre-screening can reduce the number of cancer patients, affordability remains a bigger concern, especially in lower-middle-income countries.  

Recognizing these gaps in treatment, the access experts at Axios International strategically use Axios proprietary scientific tools and real-world insights to design and implement affordable and sustainable access programs. This is why Patient Access Programs (PAPs) managed by Axios International are designed and implemented with sustainability at the core, enabling more patients to receive appropriate treatments, ​complete treatment courses, maximize adherence,​ prevent further complications and serious illnesses,​ and overall minimize the burden on hospitals, physicians, and healthcare providers.

Axios’ Proprietary Scientific Tool – PFET, Assesses The Financial Help A Patient Needs  

The Patient Financial Eligibility Tool (PFET) is a revolutionary development in the field of access to healthcare. PFET, the proprietary tool developed by Axios International, assesses the support and help a patient requires to complete a full course of treatment using evidence-based, real-world data.  

PFET has been successfully used to assess more than 23,000 patients in 30+ countries. In nine cases out of ten, patients agree to be assessed by PFET before enrolling in an Axios-partnered Patient Assistance Program (PAP). The accuracy of PFET’s assessment of a patient’s ability to pay has been verified and commended in the scientific publications Population Health Management and the Journal of Comparative Effectiveness Research.  

One of the success stories of Axios-managed Patient Assistance Programs using PFET comes from Egypt, where the program was launched to provide On-Time Access to Treatment Solutions to patients of Oncology and Hematology. According to the study, a staggering 98% of patients did not have the means to pay for prescribed medication. Even if they had insurance, they did not have funds to pay until the reimbursements arrived. Most patients began receiving treatment and used up their savings and other liquid assets long before they could get reimbursed, leading to treatments being abandoned halfway with inefficient results.  

The study also showed that due to their inability to pay for treatment, many patients neglected treatment after being diagnosed for up to three months prior to the program’s implementation. However, after enrolling in the Axios On-Time Access program, their inability to pay for treatment dropped from three months to just two days. The success of this program is evident in the fact that this number has now been reduced to an average of two days. The Egyptian public healthcare sector has expressed the wish further to support the development of the On-Time Access program to cover more areas of healthcare as well. Asia, Europe, and the Middle East are other regions with similar success rates.  

The program’s ability to ensure that patients receive ongoing care and adhere strictly to their full treatment regimens means that the medical outcomes for patients, after being assessed by PFET, are favorable. 

Once patients’ financial eligibility assessment determining their ability to pay for the treatment is complete, the next step is to enroll the patient in a program that suits their situation the most.  

To mitigate risks concerning patient data, Axios has put in place a strong compliance infrastructure in all its Access to Treatment solutions.​ All processes are aligned with the General Data Protection Regulations (GDPR). At the same time, strict data privacy controls and integrity measures are put in place for the collection, processing, usage, storage, and destruction of personal information.  

Axios-managed PAPs provide equitably affordable access solutions to diagnosis and treatment and help patients overcome their financial barriers, including limited insurance coverage, overwhelming co-pay non-reimbursements, and more. The multistakeholder approach helps Axios design and implement numerous innovative financial methods given to patients as a stand-alone or bridging/ bundled solution, helping patients access treatment. Some of the Access to Treatment Solutions include fixed schemes, tiered cost-sharing, co-pay, on-time access to treatment (short-term financing), direct-to-institution, and many more. 

Fixed Scheme support:  

Under this program, patients are given a fixed offer per the agreement without undergoing a financial eligibility assessment.  

Tiered Cost-Sharing support:  

In this program, the affordability gap that the patient is not able to bear is shared among contributing parties such as charities, NGOs, insurers, governments, pharmaceutical companies, and other potential stakeholders. Sharing the cost decreases the burden on patients and financiers and contributes to increased success rates of treatments and sustainability of the Patient Access Programs. It differs from traditional fixed schemes since patients can pay what they can afford and continue receiving treatment. 

Co-Pay Support:  

Some patients have insurance but with a monthly co-payment amount where the average patient share is 10-30 percent of the monthly medication cost. Following the PFET assessment, Axios facilitates financial support to patients based on their identified needs by offering co-pay support by issuing co-pay vouchers to cover the patient’s share, following the assessment result and quantity of support required.  

Compliance Benefit Scheme:  

This program rewards the patient for their commitment to treatment adherence. For example, if they comply with month X, they will get month Y free of charge. This innovative approach encourages compliance and their journey toward maximized adherence.   

On-Time Access To Treatment (Short-Term Financing) Support: 

This program solution is offered as a value-added service, bundled with other innovative financial treatment programs to help patients overcome cash flow shortages while waiting for support in situations such as delayed insurance reimbursement.   

Based on the individuals’ affordability needs, patients are eligible to receive this value-added service as an immediate treatment or medication support whereby a short-term credit facility is arranged on a zero-interest installment basis to cover the cost for their full course of treatment. Axios facilitates this program solution by working together with multiple stakeholders, such as financial institutions, patients, and pharmaceutical companies.  

With this timely intervention, patients can overcome any unforeseeable delays in beginning or continuing their treatment, resulting in maximized adherence to treatment.  

Since its inception in 1997, Axios International has transformed patients’ lives everywhere with its patient-centric access solutions, which help those who need it most. Carrying on its legacy of supporting patients, Axios has designed and continues to implement innovative access programs in collaboration with broader healthcare stakeholders.  

Today, thousands of patients benefit from this innovative and sustainable access to treatment solutions and programs managed by Axios. This success is apparent and proven by the measurable high success rates and the wholehearted and unbiased acceptance and benefits of the programs, services, and solutions by stakeholders and, most importantly, the patients. 

24^th November 2023

Diagnosis is complex and greatly affects a patient’s treatment journey. Imagine a healthcare journey where patients swiftly move from suspected to confirmed diagnosis, reaping the benefits of early diagnosis and minimal misdiagnoses, where barriers to access no longer exist. This vision is at the heart of Axios International’s groundbreaking intervention, “Access to Diagnosis Solutions.”

Access to Diagnosis Solutions: Navigating the Patient Diagnosis Journey

Diagnosis in the medical world is correctly identifying a problem a patient is suffering from. Access to diagnosis solutions is important for smooth and timely patient recovery.  When an individual suspects a medical condition, their path to diagnosis and treatment often compares to a maze of challenges. However, it is important to remember that Access to Diagnosis is just the first step in the 360-degree support that a patient needs during their entire treatment journey. Patients with access to solutions that detect and identify health issues, minimizing misdiagnoses, can better navigate the journey to receive the right support for timely recovery. ​Lack of awareness about diseases, delays in sharing diagnosis information with primary care physicians, complicated referral processes, and financial barriers can create challenging obstacles that increase the time taken to identify a disease before it has progressed too far.

As an example of a lung cancer scenario drawn up by Axios International of diseases like lung cancer, late diagnosis is a grave concern. Analyzing the situation, Axios International notes that many patients only receive a diagnosis when the disease has already advanced, making successful treatment less likely. The period from diagnosis to treatment initiation can stretch beyond six months, causing significant complications. This issue also extends to patients with Neuroendocrine tumors (NET), where more than 80% of cases are initially misdiagnosed, and high treatment costs are a major burden.

To address these challenges, Axios partners with multi-stakeholders, healthcare providers, hospitals, and other players in the scope of healthcare to create programs to shorten both the diagnosis timeline and the duration between identifying the health issue and the start of treatment.

Axios International’s Access to Diagnosis Solutions are designed to support short- and long-term patient and healthcare system needs. Short-term needs enhance patient access to fast and confirmed diagnosis, and this involves identifying problems with affordability and promoting quicker and easier access to necessary treatments.​ Long-term needs focus on barriers in the healthcare system through increased awareness of specific, rare, and chronic diseases among patients and through combined efforts with healthcare professionals. The more people are aware of possible health issues through awareness, the easier it is to ensure a smooth patient journey from start to end. 

Educating People about Diseases

Awareness is the first step to early diagnosis. By understanding diseases and their diagnosis and treatment, individuals will have the right knowledge to seek early diagnosis and immediate treatment. Targeted disease awareness campaigns are strategic initiatives to inform and educate specific groups or communities about a particular health condition. These campaigns are designed with lots of thought and detail and shared with communities to guarantee that information reaches the intended audience effectively. 

Axios follows two models to educate people – one through awareness campaigns and the second through a targeted reach to the patient. Axios holds disease awareness campaigns to educate the public, patients, and caregivers, with the support of healthcare providers.  We ensure our campaigns communicate the facts about the disease, its symptoms, risk factors, and available preventive measures and treatments. We also reach out to patients individually to understand their needs and develop personalized educational plans for them.

Benefits of Disease Awareness Initiatives

One of the primary goals of these campaigns is to promote early detection. Educating communities about the signs and symptoms of specific diseases makes individuals more likely to seek medical attention at the first hint of a problem.

In some cases, diseases are associated with social stigma. Targeted disease awareness campaigns work to eliminate myths and misconceptions, reducing the stigma and discrimination often faced by affected individuals.

In essence, targeted disease awareness campaigns give control to communities by providing them with the knowledge and tools they need to make informed decisions about their health. By understanding the disease better, individuals can take control of their well-being and access the care and support they require.

Financial Assistance for Patients 

We all know that healthcare can be financially burdensome. Diagnosis tests are only the beginning. From the start, some patients worry about the type of treatment cost and support they may not be able to receive and delay the diagnosis. Thus, the costs associated with diagnostic tests can be a significant barrier to healthcare access, often leading to multiple challenges. Enabling patients, therefore, in their patient journey is key.

Financial constraints can lead to patients delaying or not undertaking diagnostic tests. These worries about paying for diagnostic tests can also add emotional stress to individuals already dealing with health concerns. Lastly, patients may not fully stick to recommended diagnostic testing steps when they are concerned about the costs involved. This can lead to incomplete or inaccurate medical assessments.

Financial Support by Axios International-Partnered PAPs

With the partnership of stakeholders, Axios financially supports patients for diagnostic tests through its Patient Assistance Programs (PAPs), ensuring patients can access the care they need when needed. 

We make sure that patients are fully aware of the support available to them, how it works, and any associated terms and conditions. Transparency builds trust and empowers patients to make informed decisions about their healthcare.

Journey Management 

Navigating the healthcare system can be overwhelming. Specialist referrals, test results, and payments – it’s a lot to juggle when you’re already dealing with health concerns. However, patients must have support throughout their journey, even if the disease was detected early. Axios International is a guide and a support system, helping patients smoothly manage their journey from referrals to understanding results and supporting the patient financially as per their need for tests. It’s a patient-centric approach, putting the needs and concerns of patients at the forefront. 

One of Axios International’s key strategies is to create a network of support for patients. By engaging healthcare professionals and medical societies, we assemble a dedicated team focused on increasing the rate of early patient diagnosis for a more effective and timely treatment journey.

Transcending Barriers to Early Diagnosis

Sometimes, transport, distance, and location barriers can block your path to a diagnosis. Transportation issues, for instance, can make it difficult to reach a healthcare facility. Not everyone lives near a healthcare facility or has the means to travel for medical check-ups. Axios International takes the initiative to organize screening events and interventions, making the process more accessible for everyone. Screening events and interventions bridge this gap by directly bringing healthcare professionals and services to the communities that need them most. Instead of you going to a diagnosis facility, the diagnosis process is brought to your doorstep.

For example, screening events are proactive in nature. They are designed to detect health issues at an early stage when treatment is often more effective. Many individuals are not aware of the health risks they face. These screening events and interventions often include educational parts that inform communities about the importance of regular check-ups, recognizing symptoms, and maintaining a healthy lifestyle. By raising disease awareness, these initiatives give patients the power to take control of their health and seek medical assistance when necessary.

We design these organized activities to identify health issues early on and provide assistance, particularly for those who might face barriers in accessing healthcare. You don’t have to overcome these barriers alone; Axios patient care liaisons and access specialists are your partners in health.

The Impact and Benefits of Access to Diagnosis Solutions

Improving access to timely diagnosis is not just crucial for patients; it has a far-reaching impact on healthcare outcomes as well. The sooner a condition is diagnosed, the earlier treatment can begin. Early intervention often leads to more effective treatments. In conditions like cancer, where early detection is important, a patient’s chances of recovery can dramatically increase.

Overall, this type of patient-centric approach aims to provide compassionate and individualized care. We enable better communication between patients and healthcare providers and encourage patients to participate in informed decision-making regarding their treatment. Understanding the situation and the treatment plan helps patients to manage their emotional well-being.

On the other hand, this improved access to diagnoses prevents patients from reaching advanced stages of diseases, thereby, reducing the burden on the healthcare system. Fewer complications mean fewer emergency admissions and specialized care requirements. A healthcare system that emphasizes timely diagnoses can allocate its resources more efficiently, focusing on early interventions and preventive care.

Considering the above benefits to the healthcare ecosystem, Axios International has created a significant impact through Access to Diagnosis Solutions. Thanks to these interventions in the UAE, among many other countries that Axios operates, lung cancer, Hepatitis C, and rare diseases patients are increasingly aware of the solutions. Pulmonologists and oncologists actively engage with patients, creating greater disease awareness.

Similarly, in the case of Neuroendocrine tumors (NET), Axios International’s program has made a remarkable difference. By improving disease awareness and shortening the time to confirm diagnosis, more patients now have a fighting chance against this challenging disease.

In a world where early diagnosis and prompt treatment are essential, Axios International is pivotal in simplifying the patient’s treatment journey. By addressing barriers, increasing awareness, and offering unwavering support, they are transforming healthcare outcomes and ensuring that more patients receive the timely care they deserve.

The journey to early diagnosis and efficient treatment can be significantly enhanced with Axios International’s Access to Diagnosis Solutions. Physicians, nurses, and other healthcare professionals and patients and their caregivers have benefitted from this transformative approach that helps reach a confirmed diagnosis faster, minimizes incorrect diagnoses, and smoothly completes the patient journey. It’s not just about timely diagnoses; it’s about better personal health outcomes and a healthier healthcare system.

With Axios’ specialized solutions to improve early diagnosis and its consequent advantages, the healthcare ecosystem is one step closer to building a future that leaves no patient neglected. 

27th October 2023

In today’s digital era, healthcare solutions have the immense potential to transform patient care and empower individuals to take charge of their health and well-being. However, going beyond technical capabilities and embracing a holistic approach is important to create impactful and successful digital health tools.  

This is where the power of behavioral design and gamification comes into play. By incorporating these principles into healthcare solutions, such as apps and wearables, we can design patient-centric experiences that prioritize health and well-being. 

The World Health Organization (WHO) defines health as “a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.” It emphasizes the importance of addressing the broader aspects of well-being, encompassing mental, emotional, and social dimensions alongside physical health. In the context of digital health solutions, this holistic approach is crucial to ensure that patients receive comprehensive support and are motivated to engage with the tools we provide on a long-term basis. 

Behavioral design offers a valuable framework for understanding and addressing the multi-faceted aspects of patient well-being. By delving into patients’ motivations, preferences, and values, we can create digital health tools that resonate with their unique needs and aspirations.  

Gamification also plays a significant role in promoting overall well-being through digital health solutions. By infusing elements of play, competition, and achievement into the user experience, gamification makes the journey toward better health and well-being more enjoyable and engaging.  

How behavioral design and gamification assists healthcare solutions

Digital health solutions incorporating behavioral design and gamification can address the broader determinants of health and well-being. They can help individuals make positive lifestyle changes, manage chronic conditions, enhance mental resilience, and build supportive social networks. By focusing on the complete well-being of patients, these solutions go beyond treating symptoms or diseases, empowering individuals to lead healthier, happier lives. 

Furthermore, the success of patient-centric digital health tools relies on their ability to provide personalized experiences that cater to individuals’ unique needs and preferences. Personalization is essential for achieving the desired outcomes and sustaining patient engagement. By leveraging user data and preferences, digital health solutions can offer tailored recommendations, adaptive interventions, and relevant content that resonates with each individual’s specific well-being goals. 

Collaboration between healthcare providers, designers, and technology experts is vital to designing effective and impactful digital health solutions. Combining medical expertise with behavioral design principles and gamification strategies can create patient-centric experiences prioritizing overall well-being and bridging the gap between healthcare and technology. These solutions empower individuals to actively participate in their health and well-being journey, fostering engagement, motivation, and sustainable behavior change. 

In collaboration with our digital technology partners, Axios International is continuously developing a robust infrastructure to analyze programs, patient data, and behaviors. This innovative approach is geared towards leveraging technology with the aim of enhancing the overall experience for patients who are part of Axios-supported programs. Our incorporation of gamification and behavioral design elements sets us apart in the digital ecosystem, which promises to transform the patient experience into an enjoyable, personalized, and highly tailored journey that caters to each individual’s unique needs and circumstances. 

16th October 2023

In a world where technology touches every aspect of our lives, Digital Healthcare Access is no exception. The digital age has brought revolutionary changes, making healthcare more accessible and efficient. 

While we understand the vital role digital solutions play in improving healthcare outcomes, we also recognize that the essence of healthcare lies in the human touch, compassion, and empathy that define the patient-caregiver relationship. At Axios International, we believe in redefining healthcare by striking the perfect balance between cutting-edge digital access and the warmth of human interaction. In this article, we want to share our journey of harmonizing these two crucial elements to reshape the future of healthcare.

The Importance of Connecting Digital Healthcare with the Human Touch

We’ve witnessed the transformative power of technology in healthcare. It enables patients to connect with healthcare providers remotely, breaking geographical barriers. Telemedicine, wearable health devices, and health apps powered through essential digital health technologies like machine language (ML) and artificial intelligence (AI) empower individuals to manage their health proactively. 

Research conducted on cancer patients who did not have access to healthcare due to the high cost of medicine and shortage of specialized doctors showed a significant number of patients in contact with physicians who would regularly assess their progress and check up on their medication and side effects over the phone were alive at the end of the study in comparison to those who were not in contact with a physician. Such research supports the idea that technology can enhance healthcare outcomes, streamline processes, and boost patient engagement to the extent of supporting patients to live longer. 

However, we’ve also seen the pitfalls of technology-centric healthcare. The absence of human touch can lead to a sense of isolation where patients feel distant from the care they receive. Patients may desire reassuring face-to-face interactions with healthcare professionals. Moreover, not everyone has equal access to digital tools, potentially creating gaps in healthcare. That’s where Axios International comes into play, acting as an enabler of digital healthcare access without compromising on the human connection that patients hope for. 

How Axios International Improves Digital Healthcare Utilizing Human Touch

We bring quality care to local communities, overcoming the barriers of time and effort that patients often face when accessing healthcare. This mobile healthcare approach ensures that patients receive the care they need, where they need it.

At Axios International, as firm believers in using technology to enhance healthcare access, we’ve never lost sight of the importance of human connection. Our commitment to providing healthcare with warmth and familiarity sets us apart in the industry. 

Axios International’s strategy involves partnering and collaborating with large digital companies and tech firms with innovative concepts to make space for high levels of interaction and engagement to support patients throughout their treatment journey. We’ve achieved this through innovative services and interventions like Axios+ and Axios Remote Care Solutions.

Axios+ 

At the heart of Axios International’s mission to balance digital healthcare access with the human touch is Axios+. This isn’t just a digital platform; it’s an ecosystem designed to transform healthcare access. This comprehensive solution by Axios International aims to make quality healthcare accessible to everyone, regardless of location or economic status. Axios+ makes the maximum use of technology to create a smooth connection between patients, healthcare providers, and the broader healthcare stakeholders. 

Axios+ has already made a significant impact, being established in 22 countries and benefiting over 14,500 patients in 90 programs. Over 3,140 physicians and 1,155 referring hospitals have embraced Axios+, and its impact is life-changing. Recent case studies show that Axios+ has reduced treatment initiation times by up to 52%, allowing healthcare professionals to allocate more time to patient care, ultimately improving access to treatment.

MyHealth is another central solution of Axios+, designed to provide patients with a clear overview of their healthcare journey. It allows individuals to actively participate in their care actively, promoting a sense of control and participation. This digital solution connects patients with their healthcare data, enhancing their overall recovery experience. As it allows the exchange of critical health information between patients and healthcare providers, it ensures that the human touch is maintained throughout the digital healthcare experience.

MyPatients for Physicians

MyPatients for Physicians is another key digital solution within the Axios+ ecosystem that focuses on patient management for physicians to manage all their patient-related information under one roof. It bridges the gap between digital and traditional healthcare by offering physicians personalized updates about their patients and their journey in Axios programs. This solution caters to a wide range of individuals, ensuring that patients receive the attention and care they need in a personalized manner. 

MyPharmacy for Pharmacists

MyPharmacy for Pharmacists improves pharmacy services within the Axios+ ecosystem, making sure that managing any medicine-related need is seamless and patient-centered. This digital solution organizes the process of receiving and managing medications, reducing the burden on patients while maintaining the human connection in pharmaceutical care. By simplifying this aspect of healthcare, Axios International enhances patient experiences and minimizes disruptions to their lives.

Axios+ also comprises additional platforms dedicated to Distributors, Laboratories, NGO partners, and Pharma Sponsors, creating a fully connected ecosystem enabling patients to be supported and cared for throughout their treatment journey. 

While Axios+ represents a significant leap in balancing digital healthcare access and the human touch, Axios International goes even further with its Remote Care services. 

Remote Care

Remote Care is a complete approach to healthcare delivery. Telehealth, which is a part of remote care, makes full use of technology to provide medical services and support to patients outside of traditional healthcare settings. It includes a wide range of services, from consultations with healthcare professionals to monitoring chronic conditions, conducting diagnostic tests, and even delivering treatments—all without the need for physical visits to hospitals. 

Remote care isn’t just about convenience; it’s a necessity. Remote care benefits all stakeholders involved. In today’s fast-paced world, remote care offers a safe, convenient, and effective way for patients to receive the care they need. Patients experience improved convenience, reduced travel time, and a higher quality of care. Healthcare providers can extend their reach and provide more personalized care. Additionally, the burden on healthcare facilities is reduced, allowing them to allocate resources more efficiently.

Remote Care with Axios International 

Axios International’s Remote Care solutions are designed to bring quality healthcare including medication, directly to patients’ doorsteps, overcoming barriers of time and effort that patients would otherwise face when seeking medical attention. This approach ensures that the human touch is integrated into every aspect of care, even when patients are not physically present in a clinic or hospital. 

We understand that patients require care in the comfort of their homes or local communities, and we’ve developed a range of services to meet these needs. These services were extremely helpful during the COVID-19 pandemic and made available to as many people as possible. Amidst crisis or conflict, Axios International is keen on making sure that the majority of people can continue or start their treatment as required.

Considering these benefits, we offer an all-round package of remote care services aimed at improving the results of patient health conditions and enhancing their overall quality of life without letting go of the human connection. The human touch in healthcare extends beyond the physical aspects of care; it includes empathy, understanding, and the personal connection between healthcare providers and patients. We understand that the human touch is an irreplaceable element of quality care and have made it a vital part of our Remote Care solutions.

Personalized Nursing Care

Our licensed and registered nurses provide high-quality care tailored to the patient’s specific needs. This personalized approach ensures that patients receive the right care, in the right place, and at the right time.

Screening and Diagnostic Monitoring

We offer innovative diagnostic tests at home, reducing the time needed for diagnosis and speeding up the beginning of treatment. This not only improves patient outcomes but also reduces the anxiety associated with waiting for test results, ensuring that patients feel cared for even when they are not in a clinical setting.

Rehabilitation and Physical Therapy

Our remote rehabilitation and physiotherapy services help patients regain their physical abilities and improve their quality of life. This is particularly important for individuals recovering from injuries or surgeries. This approach bridges the gap between technology-driven care and the personal connection that is so vital in the healing process.

Weight Management and Nutrition Counseling

We take a holistic approach to healthcare, addressing not only medical needs but also lifestyle factors. Our personalized dietary guidance, developed by licensed nutritionists, helps patients improve their overall health and well-being. This human-centered approach develops a sense of partnership between patients and their healthcare providers.

Mobile Healthcare

We bring quality care to local communities, overcoming the barriers of time and effort that patients often face when accessing healthcare. This mobile healthcare approach ensures that patients receive the care they need, where they need it.

Behavioural and Life Coaching

Recognizing the importance of mental and emotional well-being, we offer coaching to help patients adopt healthier behaviors and engage actively in their journey toward better health. This service recognizes that healthcare is not just about treating physical conditions but also about supporting patients in their overall well-being.

Key Takeaways

In a rapidly evolving world of digital healthcare, Axios International stands as a sign of innovation and compassion. We understand the power of technology in improving healthcare access and results without forgetting the essence of human connection. Our commitment to effortlessly blending cutting-edge digital healthcare access with the warmth of human interaction reshapes healthcare into a more connected, compassionate, and effective experience. 

Axios International continues to provide more communities across the globe with digital healthcare access through our innovative Axios+ ecosystem and Remote Care solutions, where technology and humanity unite to create a brighter, healthier future. Embrace this balance with us, and together, we can redefine healthcare for the better.

30th August 2023

It is time for healthcare to transcend its traditional boundaries and embark on a new era of patient empowerment and collaboration, where adherence becomes a cornerstone of improved healthcare outcomes. The time for change is now.

Recognizing patients’ continuously evolving needs throughout their healthcare journey holds paramount importance. Mere acknowledgment of these needs falls short, while proactive, efficient, and continuous addressing of these needs is essential to overcome the numerous adherence barriers that hinder patients from accessing essential care. This underscores the urgent need to develop a transformative and all-encompassing solution customized to the broad spectrum of patients’ requirements. Such a solution must be guided by a scientific yet holistic approach to ensure effective development. 

Approach to patient adherence

The holistic approach to access to adherence acknowledges the multifaceted nature of a person’s life. It recognizes that effective treatment compliance requires a comprehensive understanding of the individual and their circumstances. By considering multiple factors based on the different methodologies that impact disease self-management, the holistic approach aims to promote patient-centric care and a personalized support model that helps individuals successfully overcome the barriers to healthcare.

Adherence to treatment is rooted in creating an environment where patients can thrive. By offering adherence to treatment solutions, we can undertake a holistic approach to create an ecosystem that can improve a patient’s life and encapsulate how patients cope with disease from the first signs and symptoms that they experience to throughout their full journey, thereby empowering them with all tools to be able to cope with a lifelong disease. This all-encompassing and thorough method acknowledges the interplay of diverse factors that impact an individual’s capacity to adhere to their healthcare provider’s advice. It extends beyond mere medication adherence and considers the broader environment in which the individual operates. 

Non-adherence to prescribed treatment can lead to suboptimal health outcomes such as disease progression, hospitalization, reduced quality of life, and serious or irreversible complications. Non-adherence increases the burden on health systems at a time when there are ever-greater demands on healthcare resources. A gap in patient adherence to treatment could collapse the healthcare ecosystem; thus, adherence support solutions are critical to achieving optimal medical outcomes.  

The traditional approach within the healthcare system has relied upon a limited range of interventions to foster patient adherence. Typically, patients are warned about the potential consequences of non-adherence, while standardized follow-up consultations are scheduled for the entire patient population. Unfortunately, this one-size-fits-all approach fails to account for individual patients’ unique circumstances and diverse needs. Consequently, billions of dollars are spent on interventions that may only be effective for some or unsustainable patient support programs.  

This emphasizes the need to innovate a multi-layered scientific approach to effectively address the World Health Organization’s (WHO) five dimensions of adherence. WHO defines adherence as “the degree to which the person’s behavior corresponds with the agreed recommendations from a healthcare provider.” It also adds that 80 percent or more adherence rates are typically needed for optimal therapeutic efficacy. But poor adherence to therapy is a significant public health problem, averaging only 50 percent in developed countries and even lower in developing countries. As outlined by WHO in its dimensions, patients’ therapeutic outcomes are affected by factors such as social and economic as well as therapy, disease, patient, and healthcare system-related factors. Therefore, we must draw inspiration from successful strategies that relevant industries, policymakers, regulators, researchers, and entrepreneurs employ to tackle this challenge. Each patient’s journey is unique – equitable, and sustainable. Healthcare access solutions should be designed to address patient adherence challenges in a personalized way.  

Care and treatment extend beyond mere medication. The importance of establishing a patient-centric care ecosystem is more apparent than ever. Embracing a comprehensive, multi-dimensional view of each individual’s journey allows us to delve into their adherence support routines and the fundamental factors shaping their behaviors. This encompasses demographics, lifestyle decisions, and more. 

At Axios International, we look at the patient journey holistically and provide tailored, personalized adherence interventions for each patient because each is different. Adopting an evidence-based approach, our proprietary Patient Needs Assessment Tool (PNAT) customizes services to each patient, thereby increasing adherence, engagement, and program cost-efficiency​. The patient undergoes personal needs assessment using PNAT to determine the support they need, based on which a personalized Patient Support Program (PSP) is developed, resulting in improved medical outcomes.  

Only by utilizing the validated scientific tools to assess and identify the unmet needs of the patients in a customized approach and understanding the variations in patient adherence patterns and individual motivations can healthcare providers customize interventions to address the specific needs of patients who require additional support to maximize their medical benefit. For instance, one patient may discontinue therapy due to intolerable side effects, the inconvenience of doctor visits, and apprehension about being reprimanded for non-adherence. Conversely, another patient with the same diagnosis may frequently skip doses due to a demanding lifestyle, frequent travel, and a lack of comprehension regarding the severity of their condition. Recognizing these nuanced differences is pivotal in devising effective access strategies and solutions that cater to each patient’s needs. To provide care and treatment in the right place at the right time, a broad range of cost-competitive access to adherence solutions, including remote care and other support solutions, can ensure that patients and their families can access care and treatment services where and when they need the most.  

However, interventions alone are insufficient. All stakeholders, including the community, must embrace agility by creating an eco-system that encourages innovation in designing, executing, monitoring, and continuously evolving access solutions based on emerging unmet needs during a patient’s journey. Partnering with access to healthcare providers can also help track the effectiveness of interventions at both the individual and segment levels and help make improvements to enhance success rates. These improvements also necessitate collaboration across functions such as research and development, product development, medical, and patient services, while dedicated resources equipped with specialized skills in communications, technology, data analytics, quality, and compliance facilitate coordinated execution across all channels.  

Healthcare providers must adopt a 360-degree patient support approach to revolutionize patient adherence. By doing so, they can enhance adherence rates, curtail unsustainable practices in healthcare systems, and enhance quality of life by improving patient health and medical outcomes. Achieving this transformation demands the seamless integration of predictive analytics, personalized patient adherence interventions, and agile operational frameworks, all with the primary goal of empowering patients to engage in their healthcare journeys actively. The present moment beckons healthcare to transcend conventional confines and usher in a fresh era of patient empowerment and collaboration, where adherence is a cornerstone of better healthcare results. 

30th May 2023

Understanding a patient’s journey – prior to diagnosis all the way till after treatment – is pivotal to maximizing the potential of novel therapies and patient support services. In today’s world, the healthcare industry is leveraging real-world data to improve medical outcomes and discern this journey. Over the last decade, there has been significant growth in the availability of real-world data sources. However, more accurate data is needed to understand how specific access or patient support interventions affect patients’ health outcomes. Such data is vital for several reasons. It can help doctors make better decisions about a patient’s treatment, help healthcare providers optimize access to their medications and treatments, and help governments or other payers decide how to support the cost of treatment and determine the overall impact. The gathered data interests all stakeholders, and its insights help develop a sustainable healthcare ecosystem centered around patients. 

With 25 years of global experience and local expertise in implementing Patient Assistant Programs (PAPs) and Patient Support Programs (PSPs) to over 9.5 million patients in over 100 countries, Axios International is uniquely positioned to offer specialized solutions to address these challenges through Real World Insights. RWI is significant in identifying critical factors impacting patients’ health outcomes and ensuring that these insights are used to improve healthcare deliveries to support needy patients across emerging markets.   

Bridging the healthcare access gap through Real-World Insights

RWI is the result of the core activities Axios International undertakes. It has been designed to draw learnings from the healthcare access initiatives implemented in over 100 countries and help Axios improve its existing programs to create better patient benefits and contribute towards better access. Through its daily work, Axios has access to insights and understanding of how a patient’s journey should differ from Malaysia to the United Arab Emirates (UAE) to Mexico. This information is analyzed systematically to understand how Axios can improve how it supports patients and, most importantly, contribute to broader access.   

The ability to comprehend these realities stems from the privilege of working closely with patients, their healthcare providers, and other stakeholders in their treatment journey, having developed a clear understanding that >70% of a patient’s journey happens once they leave the clinical settings. This experience allows us to gather insights that are safe and compliant with all privacy standards, such as the General Data Protection Regulation (GDPR) and any local privacy data laws applicable in the countries where Axios programs have been implemented, ensuring a compliant approach. Using the same process, Axios also ensures patients’ boundaries are considered. The focus is on providing data security while expanding patient access and using these insights only to support broader access. With RWI, we can systematically analyze, learn, and improve from our thousands of patient support and assistance programs and help demonstrate the value of the access initiatives.   

Ultimately, Axios International RWI’s scientific and patient-centric approach is to learn and identify potential affordability, care, and treatment accessibility barriers in the patient journey and improve the level of support provided through Axios access initiatives. These barriers can be overcome by understanding how to reach optimal treatment plans that suit the needs of the patients in the space outside the hospital or healthcare facility, increasing the rate of adherence to treatment, and ultimately, reducing the disease burden and strengthening the local healthcare landscape. It also helps shape how healthcare is delivered to patients wherever they are in a pragmatic patient-centric approach. In essence, RWI helps map out the entire patient journey unique to each patient, identify potential barriers, and improve the level of support through access initiatives across emerging markets.   

Space outside the hospital

Working with patients since Axios launched the first anti-retroviral and cancer programs 25 years ago, one unique factor seen in every country is that most of the patients’ journey happens in space outside the hospital or healthcare facility. A patient sees the doctor and spends five or twenty minutes with a physician, depending on where they are in the world, and then goes home. That disease burden, for instance, having multiple treatments throughout the day, remains with the patient, the family, and the caregiver. RWI helps us understand what happens in that space outside the hospital and how to create a more connected healthcare system between the stakeholders to help improve treatment outcomes.  

Axios RWI outcomes from a recent study demonstrate a difference in the impact and duration of treatment of a patient and is an apt example of how the company contributes to shaping broader access. The study shows how the type of intervention done during follow-up may influence the patient’s ability to continue to take treatment; Axios RWI helped us learn that patients who received a phone call with a personalized touch ended up staying on treatment longer compared to digital-only follow-ups via apps or email. In this case, the impact of using digital as an enabler was demonstrated rather than as a tool to replace that human touch.   

Real-world, access-focused insights can aid in identifying the unmet needs of patient populations, improving the overall patient experience. In addition, access-focused data can help facilitate solutions by supporting evidence-based decision-making by all stakeholders involved in the treatment journey – from the patient who experiences the symptom to the doctor that first diagnoses and prescribes treatment to the patient, to the company that manufactures the therapy, to the government that decides how to make the treatment available to that population and develops best-in-class guidelines and policies.   

Enhancing the patient journey, Axios RWI further helps deliver breakthrough insights on the disease evolution, treatment, patients’ perceptions, outcomes, and costs. By creating 360-degree value through data from all stakeholders, RWI supports patients in achieving better health outcomes.   

18 May, 2023

Axios International has undergone a significant transformation since it was established in 1997. From its humble beginnings to its current status as a leading access to healthcare firm, Axios has demonstrated a relentless commitment to change and innovation. The Company’s ever-evolving and unwavering focus on never standing still, the impact of our actions on patients, and the challenges posed by our diverse global workforce make Axios what it is today. 

In 2009, Axios had a distinct organizational structure. It operated like a Professional Services (consultancy) firm with notable service lines and offices in the US, Europe, Africa and Asia. However, over the past 10 years, the organization has undergone a structural overhaul, shifting its focus towards implementation and diversifying its client base and program offerings. 

Between 2012 and 2014, Axios faced a fundamental shift that required us to reassess our direction to evolve while continuing to implement strategies and patient support programs. The company was expanding into the Middle East and had started looking at its access solutions from a 360-degree angle. The company’s contraction necessitated stretching capacities and adapting to new challenges. This period of transformation allowed the company to go beyond the traditional boundaries, encouraging everyone to explore diverse roles and contribute to various departments within the organization.  

#NeverStandingStill: 

One of the most striking aspects of working at Axios is the company’s focus on never standing still and embracing change to always find a solution. This agile approach enables us to implement changes quickly without dwelling on complex bureaucratic procedures. Although challenges and pushback are not uncommon, the pace and open-mindedness of Axios foster a dynamic work environment. 

The philosophy of never standing still also translates into tangible health outcomes for patients. Axios constantly drives change and maintains a patient-centric focus, ensuring treatments remain uninterrupted and patients receive the support they need. Even during the challenging COVID-19 pandemic, Axios employees demonstrated an unwavering commitment, going above and beyond to serve patients by embodying the spirit of “leave no patient behind.” The passion and dedication exhibited by our global workforce had a profound impact during this time, and the organization’s flexibility and adaptability were critical in navigating the crisis. 

Axios is a complex organization because of its geographical footprint and presence in several countries. With 40 different nationalities represented within Axios in 20 different countries, the diverse workforce presents unique opportunities. Effective communication and collaboration across multiple time zones and cultures require a mindful and tailored approach. Understanding and respecting the distinct Axios’ experiences of employees in various locations is crucial, as different regions may have different rhythms, routines, and ways of doing things. Balancing the need for clear communication while adapting messages to suit different audiences remains an ongoing challenge. 

While being at the right place, at the right time, and with the right information is crucial, having the right people is even more important. But when it comes to the right people, skilled access experts from Axios work together with every other stakeholder to enable access for our patients. As an organization, Axios prioritizes growth, embraces change, and remains committed to the well-being of patients. The evolution from a consultancy firm to an implementation-focused entity has reshaped how the company operates and strengthened its impact.  

Axios believes in driving change through a people-first approach; therefore, people management and development are key priorities for Axios. With effective people, operational controls, and administrative and reporting procedures, Axios champions a better working environment by focusing on employee mental health and well-being. 

As we navigate the challenges of a diverse workforce, Axios continues to adapt and thrive, setting new standards for innovation and patient-centricity in the industry.